User: Guest

  

Most R&D budgets which are so vital for innovation are largely dependent upon financial support from governments. Healthy financial performance of companies also determines the extent of willingness to reinvest earnings into R&D and new product development. The COVID-19 induced recession has now cast serious questions on the ability of governments and companies to earmark financial commitments in times of crisis. Academic and industrial research is expected to come under the yoke as immediate focus on surviving the downturn lowers the appetite for both indigenous innovation and international collaboration. Lockdowns imposed in countries worldwide has shutdown laboratories, stifled supply chains and slowed down R&D projects in companies. The modern innovation ecosystem is tightly integrated and interconnected with multiple players in the industry. This close R&D cooperation is expected to emerge into the Achilles Heel of the R&D industry during this recession. In addition to temporary inability to connect with partners, longer-term financing tightness will be the bigger blow to the industry. Under this backdrop, the market for marine biotechnology, which is heavily dependent on R&D, is expected to come under immense pressure. A revised analysis puts the global market size at US$5. 4 billion for the year 2027. With the current recession expected to be the worst ever recession since the Great Recession of 2009, companies have already begun to rethink their strategies and the departments which face cuts most often in times of crisis are R&D departments. The only hope for the market in successfully mitigating the short- and long-term damage of the crisis, is securing fiscal stimulus from governments. However, the commitment of pandemic scarred deficit widened governments in funding innovation ecosystems is yet to be seen.

In the meantime, marine biotechnology research in all applications except healthcarewill decline. While the economy is running out of money, biopharmaceutical research is landing big bucks as the world desperately seeks ways to treat, cure and stop the spread of the disease. Universities and top pharma industry R&D teams will continue to work together to address the pandemic. All hopes are pinned on biopharmaceutical innovation for a medical breakthrough to fight COVID-19. Biopharmaceutical companies are witnessing their market cap rise significantly. The COVID tragedy will be the beginning of biotech revolution and innovation in treating diseases and developing vaccines. While the global economy slows down, pharma biotechnology firms both big and small will fearlessly continue to innovate and bring hope. This brings good news for healthcare applications of marine biotechnology. The potential to derive antiviral agents from marine fungi will be fully exploited now more than ever. Already, marine red algae are being researched for use as a coating material on surfaces & objects to curb the spread the disease & also in the production of antiviral drugs to fight COVID-19.

Given the fact that the rise of the "circular economy" as the blueprint for a new sustainable economy in the 21st century will become even more important in the post COVID-19 era, the market's growth fundamentals will bounce back in-sync with the improvement in economic climate. In the age of "Sustainalism", marine biotechnology will steal the spotlight as it carries an ocean of answers to several of the stubborn conventional polluting practices currently adopted. From addressing the plastics threat by using marine organisms to produce eco-friendly chemicals like biopolymers, developing microbial energy as an environmentally-friendly alternative to crude oil and gas to developing natural and safe life-saving pharmaceuticals, marine biotechnology holds answers to several of the most urgent and pressing questions faced today. Bioplastics and biopolymers will continue to look towards new advances made in marine biotechnology to develop completely new class of biodegradable biopolymers. New research till-date, has revealed the ability to process crabs, shrimp, and prawn biowastes into naturally occurring biopolymers "chitin" and "chitosan". Chitosan, like Polylactic acid (PLA), also features beneficial characteristics such as biocompatibility, biodegradability, non-toxicity, antimicrobial activity, high mechanical strength, and chemical inertness. Marine biotechnology also immensely influences the energy industry. The development of new ways to produce microbial energy and microbial energy conversion holds immense promise in utilizing available forest biomass inventory for generating electricity. New concepts like "Microbial Fuel Cells" are also taking flight backed by the progress made in this field. While food crops and ligno-cellulosic plant biomass have long been studied and commercialized as an alternative feedstock for biofuels production, new developments in marine biotechnology are helping bring even marine macro algae "Ulva Lactuca" as a potential feedstock for the production of bio-ethanol and biogas production. Energy production from marine biomass is therefore an exciting example of how marine biotechnology can change our energy production practices.

Another industry that has and will continue to witness the revolutionizing influence of marine biotechnology is the pharmaceutical industry. Pharma companies plunge into the seas in search of newer, safer, natural and more effective drugs. Marine organisms-derived chemicals have the advantage of abundance and can be easily produced in large scale. New discoveries and development of marine peptides will drive growth of peptide therapeutics in the coming years. Bioactive marine compounds developed so far include Alkaloids, Lactones, Hydroxybenzene, Quinones, Peptides, Sterides, Aether, and Ketal. Marine-derived pharmaceuticals are already making an impact on therapeutic areas such as anti-cancer, anti-bacterial, anti-fungus, anti-virus, pest resistance, and pulmonary hypertensive vascular disease (PHVD), among others. Nutraceuticals, cosmetics and antibiotics will witness the biggest impact, followed by bioactives and bio-assays in clinical diagnostics. With numerous pharmacological properties waiting to be exploited, there are strong investment opportunities for further research in this space. Environmental remediation also represents another interesting area of opportunity with new biotechnological approaches helping develop novel biosensing technologies, and anti-fouling technologies for protection and management of the environment.

DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

6614

Interactions with Platform & by Email *

INTERACTIONS

1058

Unique # Participated *

PARTICIPANTS

198

Responses Validated *

VALIDATIONS

43

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   A Quick Primer.....II-11$100
   Marine Biotechnology: A Science to Address Global Challenges.....II-21$100
   Current and Future Analysis.....II-31$100
   Impact of Economic Uncertainty in Retrospect.....II-41$100
   Noteworthy Trends & Issues.....II-5
Medical, Food and Cosmetic Sectors Garner Research Dollars.....II-5
Select Marine Bio-Products Commercially Available.....II-5
Health-Promoting Benefits of Marine Algal Proteins.....II-5
1$100
   Sea Anemone Toxins: Opportunities for Pharma & Agricultural Sectors.....II-6
Marine Worm: Potential Role in Medical Applications.....II-6
1$100
   Coral Reefs Offer Abundant Opportunities.....II-7
Marine Microalgae: Promising Potential in Varied Industries.....II-7
1$100
   Commercially Cultivated Marine Microalgae Species and their Applications.....II-8
Major Applications of Marine Microalgae Biomass or their Extracts.....II-8
1$100
   Polysaccharides from Marine Microalgae Holds Tremendous Potential.....II-9
Select Marine Microalgae Species Producing Polysaccharides.....II-9
1$100
   Carotenoids of Marine Origin: Key Applications.....II-10
Major Commercially Available Carotenoids.....II-10
1$100
   Rising Demand for HVAB’s: Threat to Marine Biodiversity?.....II-11
Marine Ingredients for Bonding Applications: A Research Focus.....II-11
Biopharmaceutical Companies Shift towards Marine Natural Products.....II-11
1$100
   Technology Advancements Aid Research Activities.....II-12
Partnerships: Vital for Development of Marine Biotechnology Research.....II-12
2$200
   Megaprojects Hold Significance for Marine Biotechnology Development.....II-14
Lack of R&D Investment in Marine Biotech: A Challenge.....II-14
1$100
   Preserving Marine Ecology: A Prime Concern.....II-151$100
   Marine Biotechnology for Sustainable Production of Healthy Food Products.....II-16 1$100
   Table 1: World Population by Geographic Region (2000-2050) (in Millions) (includes corresponding Graph/Chart).....II-171$350
   Table 2: Top 5 Seafood Consuming Nations Based on Per-Capita Intake (2013) (includes corresponding Graph/Chart).....II-18

Table 3: World Aquaculture Market (2012): Breakdown of Production Volume by Region (in ‘000 Tonnes) (includes corresponding Graph/Chart).....II-18
1$350
   Table 4: World Capture Fisheries and Aquaculture Market (2013): Percentage Breakdown of Production Volume by Inland and Marine Segments (includes corresponding Graph/Chart).....II-19

Table 5: Global Aquaculture Market (2013): Percentage Share Breakdown of Production Volume by Fish Type (includes corresponding Graph/Chart).....II-19
2$350
   Marine Resources as Functional Food Ingredients.....II-211$100
   Health Benefits of Few Marine-derived Functional Food Ingredients.....II-221$100
   Marine-Derived Nutraceuticals.....II-23
Major Marine Nutraceutical Products: A Glance.....II-23
1$100
   Global Omega-3 Ingredients Market – A Review.....II-24 1$100
   Table 6: World Omega-3 Dietary Supplements Market (2013): Percentage Share Breakdown of Volume Sales by Geographic Region - North America, Europe, Asia-Pacific, and Rest of World (includes corresponding Graph/Chart).....II-25
Marine Biotechnology for Energy Supply.....II-25
1$350
   Feasibility of Using Algae for Biofuel Production.....II-26
Application of Marine Organisms in the Cosmetics Industry.....II-26
1$100
   Marine Ingredients in Cosmetics Industry.....II-27
Focus Shifts to Sustainable Sourcing of Marine Ingredients in Cosmetics
  Industry.....II-27
1$100
   Marine Biotechnology for Industrial Processing.....II-281$100
   Marine Microbial Enzymes.....II-291$100
   Marine-Derived Biopolymers & Biomaterials.....II-30
Marine Micro & Macro Algae.....II-30
1$100
   Chitin & Chitosan.....II-311$100
   Marine Bacteria.....II-32
Bioceramics.....II-32
Extremozymes.....II-32
1$100
   Marine Biotechnology for Protecting Marine Ecosystems.....II-33
Biofouling.....II-33
Detecting Marine Pathogenic Organisms.....II-33
1$100
   Bioremediation of Marine Ecosystems.....II-34
Marine Coatings Market.....II-34
Marine-Derived Pharmaceuticals.....II-34
Brief History.....II-34
1$100
   Major Marine Sources for Drugs.....II-35
Applications of Marine Products in Pharmaceutical Industry.....II-35
1$100
   Invertebrates – Major Focus of Research.....II-36
Marine Flora – Largely Unexplored.....II-36
1$100
   Research Focus Entrenched on Marine Drugs.....II-371$100
   Marine Pharmaceutical Products - Development/Approval Status (2014).....II-381$100
   Robust Clinical Pipeline to Support Growth.....II-391$100
   Anti-Cancer Drugs Dominate Drug Development Pipeline.....II-40
Overview of Approved Anti-Tumor Drugs of Marine Origin.....II-40
1$100
   PharmaMar: Undisputed Leader in Oncology Medicines of Marine Origin.....II-41
Cardiovascular Marine Products.....II-41
Cardiovascular Marine Products by Marine Source.....II-41
1$100
   An Overview of Select Cardiovascular Marine Products.....II-42
Key Challenges in Discovery of Marine-derived Drugs.....II-42
1$100
   Marine Genetic Resources: Regulatory Framework.....II-43
The Convention on Biological Diversity (CBD) and the Nagoya Protocol.....II-43
1$100
   The United Nations Convention on the Law of the Sea.....II-441$100
   Overview.....II-451$100
   R&D Initiatives, Funding Programs & Research Priorities for Marine
  Biotechnology.....II-46
The United States.....II-46
1$100
   Canada.....II-47
Japan.....II-47
Europe.....II-47
1$100
   Turkey.....II-48
Asia.....II-48
Australia & New Zealand.....II-48
1$100
   China.....II-49
India.....II-49
South Korea.....II-49
Southeast Asia.....II-49
1$100
   Latin America.....II-50
Middle East & Africa.....II-50
International Efforts in Marine Biotechnology Research.....II-50
1$100
   Major R&D Projects in Marine Biotechnology Space.....II-51
EU Embarks on Ground-Breaking Marine Plankton Project.....II-51
KIOST Augments Research on Marine Biotechnology.....II-51
EU Launches BlueGenics Research Project.....II-51
1$100
   Smithsonian Tropical Research Institute to Launch Global Marine Biodiversity
  Project.....II-52
1$100
   Prelude.....II-53
Significance of Marine Biodiversity.....II-53
1$100
   Marine Biotechnology: Definition.....II-54
Why are Marine Organisms Crucial?.....II-54
1$100
   Sources of Marine Biotech Products.....II-55
Key Marine Sources and Products.....II-55
1$100
   Select Marine-Derived Products.....II-56
Marine Sponges.....II-56
Marine Plants.....II-56
Protista.....II-56
1$100
   Marine Bacteria.....II-57
Marine Fungi.....II-57
Types of Marine Biotech Products.....II-57
Marine Biomaterials.....II-57
Marine Adhesives.....II-57
1$100
   Marine Bioactive Substances.....II-58
Enzymes.....II-58
Haloperoxidase Enzymes.....II-58
Thermostable DNA-Modifying Enzymes.....II-58
1$100
   Other Marine Products and Processes.....II-59
Marine Biomass.....II-59
Marine Bio-Process.....II-59
Significant Bio-Processes and their Applications.....II-59
End-Use Analysis.....II-59
1$100
   Foods.....II-601$100
   Nutraceuticals.....II-61
Medicine.....II-61
Cosmetics.....II-61
Research Tools.....II-61
1$100
   Processing Technologies.....II-62
New Energy Sources.....II-62
Agriculture.....II-62
Industrial.....II-62
1$100
   Food Safety.....II-63
Environmental Management.....II-63
Bioremediation.....II-63
Marine Biosurfactants.....II-63
1$100
   Select Biosurfactants Produced from Marine Microorganisms.....II-64
Aquaculture and Marine Biotechnology.....II-64
Industrial Applications.....II-64
1$100
   Healthcare.....II-65
Select Marine Diterpenes and Their Biological Activity.....II-65
1$100
   Bioprospecting.....II-66
Consumer Products.....II-66
1$100
   Select Macroalgal Materials and Applications in Cosmetic Industry.....II-67
Public Services and Infrastructure.....II-67
Others.....II-67
An Insight into Select Marine-Origin Products.....II-67
Agar.....II-67
1$100
   Major Seaweeds Used for Extracting Agar and Agarose.....II-68
Alginate.....II-68
1$100
   Astaxanthin.....II-69
Carrageenan.....II-69
1$100
   Chitin and Chitosan.....II-70
Chitin.....II-70
Chitosan.....II-70
Select Industrial Applications of Chitosan.....II-70
1$100
   Collagen.....II-71
Salmon Calcitonin.....II-71
1$100
   New Research Finding Reveals the Role of Opisthobranchs in Lignarenones
  Biosynthesis.....II-72
Norwegian Researchers Explore Potential of Tunicate as a Source of Biofuel and Fish
  Feed.....II-72
1$100
   Scientists Unearth Medicinal Properties of Marine Enzyme, Bacillus
  Licheniformis.....II-73
Salmon Peptone for Producing High-Value Biotech Products.....II-73
Norwegian Researchers Study Potential of Farmed Salmon Waste as Nutrients to Nourish
  Kelp and Mussel.....II-73
Researchers Study Effectiveness of Alginate Supplementation on Weight Loss.....II-73
1$100
   Lamellarins Can Stop Cancer Drug Resistance: New Finding on Marine Natural
  Product.....II-74
Evaluation of DHA and EPA Concentration in Algal Species.....II-74
1$100
   Study of Potential Applications of Delesseria Sanguinea.....II-75
Scientists Use Bacteria Occurring in Marine Waters to Develop New Assays.....II-75
1$100
   BiotechMarine Develops Sea Shine.....II-76
Lipotec Launches Seacode™.....II-76
Bluewave Marine Ingredients Launches AminoMarine™ Fish Protein Powder.....II-76
Cyvex Nutrition Rolls Out Protomine™ Fish Protein Powder.....II-76
Lipotec Unveils Seacode Marine-based Anti-Ageing Ingredient.....II-76
Marie Veronique Organics Rolls Out Pacific Line of Anti-Aging Products.....II-76
DSM Unveils DHA plus EPA™ Product.....II-76
1$100
   Aqua Bio Technology Launches New Marine-Based Ingredients.....II-77
La Prairie Launches Lifestyle Collection.....II-77
1$100
   Superba™ Krill Oil Receives Regulatory Approval in India.....II-78
GlycoMar Collaborates With Biopol.....II-78
Aker Biomarine Inks Licensing Agreement with Neptune.....II-78
Aker BioMarine Inks Distribution Agreement with BioMar.....II-78
HEMARINA Inks Deal with LFB Bio-Manufacturing.....II-78
Lallemand Takes Over Aquapharm.....II-78
1$100
   BASF Acquires Pronova.....II-79
FMC Takes Over Epax.....II-79
Seppic Takes Over BiotechMarine.....II-79
Aqua Bio Technology Bags Contracts from Cosmetics Company.....II-79
CRBM and CNBE Ink Marine Biotechnology Agreement.....II-79
Olympic Seafood Enters into Long-Term Licensing Agreement with Aker BioMarine.....II-79
Stemtech International Inks Agreement with Marinova.....II-79
ABT Bags Multi Million Contract from Restorsea for Aquabeautine XL™
  Ingredient.....II-79
1$100
   Aquapharm Collaborates with c-LEcta.....II-80
Aqua Bio Technology Signs Agreement with Amway.....II-80
Aquapharm Enters into Partnership with Aqua Bio Technology.....II-80
1$100
   Aker BioMarine AS (Norway).....II-81
Aqua Bio Technology ASA (Norway).....II-81
BASF SE (Germany).....II-81
1$100
   CP Kelco (US).....II-82
Cyanotech Corp. (US).....II-82
Nutrex Hawaii (US).....II-82
1$100
   FMC Health and Nutrition (US).....II-83
NovaMatrix (Norway).....II-83
GlycoMar Ltd. (UK).....II-83
1$100
   Jazz Pharmaceuticals plc (Ireland).....II-84
Lonza Group Ltd. (Switzerland).....II-84
Marinova Pty Ltd (Australia).....II-84
1$100
   New England Biolabs Inc (US).....II-85
oceanBASIS GmbH (Germany).....II-85
PharmaMar S.A (Spain).....II-85
1$100
   PML Applications Ltd. (UK).....II-86
Prolume Ltd (US).....II-86
BioLume®, Inc. (US).....II-86
1$100
   Royal DSM N.V (Netherlands).....II-87
Sea Run Holdings, Inc. (US).....II-87
SEPPIC (France).....II-87
1$100
   Biotech Marine (France).....II-88
Tequesta BioVentures (US).....II-88
1$100
   Table 7: World Recent Past, Current & Future Analysis for Marine Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-891$350
   Table 8: World Historic Review for Marine Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....II-901$350
   Table 9: World 15-Year Perspective for Marine Biotechnology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart).....II-911$350
   Table 10: World Recent Past, Current & Future Analysis for Marine Biotechnology by Product Segment - Biomaterials, Bioactive Substances, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-921$350
   Table 11: World Historic Review for Marine Biotechnology by Product Segment - Biomaterials, Bioactive Substances, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....II-931$350
   Table 12: World 15-Year Perspective for Marine Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Biomaterials, Bioactive Substances, and Other Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart).....II-941$350
   Table 13: World Recent Past, Current & Future Analysis for Marine Biotechnology by End-Use Application - Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....II-951$350
   Table 14: World Historic Review for Marine Biotechnology by End-Use Application - Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....II-961$350
   Table 15: World 15-Year Perspective for Marine Biotechnology by End-Use Application - Percentage Breakdown of Dollar Sales for Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure and Other Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart).....II-971$350
   A. Market Analysis.....III-1
Overview.....III-1
Aquaculture Biotechnology.....III-1
Policy Framework to Offer Support for Marine Biotechnology.....III-1
1$75
   Product Introductions/Innovations.....III-2
Strategic Corporate Developments.....III-2
1$75
   Key Players.....III-33$225
   B. Market Analytics.....III-6
Table 16: US Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-6
1$200
   Table 17: US Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-71$200
   A. Market Analysis.....III-8
Outlook.....III-8
Strategic Corporate Development.....III-8
1$75
   B. Market Analytics.....III-9
Table 18: Canadian Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-9
1$200
   Table 19: Canadian Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-101$200
   A. Market Analysis.....III-11
Outlook.....III-11
B. Market Analytics.....III-11
Table 20: Japanese Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-11
1$200
   Table 21: Japanese Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-121$200
   A. Market Analysis.....III-13
Marine Biotechnology: Promising Opportunities for Europe.....III-13
A Nascent Yet Promising Market.....III-13
1$75
   Marine and Algae Oils Market in Europe: An Overview.....III-14
Prospects for Blue Technology in Baltic Sea Region.....III-14
1$75
   A Distinct Identity for Marine Biotechnology: The Way Forward.....III-15
Marine Drug Discovery: Need for Diversifying Research Focus.....III-15
Regulations Governing Marine Biotechnology in Europe.....III-15
1$75
   A Glance at Key Documents & Events Focused on Marine Biotechnology.....III-161$75
   Initiatives for Marine Biotechnology Growth.....III-171$75
   The European Commission Policies on Blue Technology (Marine and Freshwater
  Biotechnology).....III-18
1$75
   Horizon 2020: Aiming for Faster Marketability of Innovations.....III-19
ERA-NET.....III-19
Focus on Select Regional Markets.....III-19
Belgium.....III-19
1$75
   Denmark.....III-20
Germany.....III-20
North Germany Focuses on Maritime Resources.....III-20
Ireland.....III-20
1$75
   Norway.....III-21
Overview.....III-21
Norway Leads in Bioprospecting Arctic Genetic Resources in Nordic
  Countries.....III-21
1$75
   Market Participants.....III-22
Industrial Applications.....III-22
Pharmaceuticals.....III-22
Norwegian Marine Biotechnology Companies.....III-22
2$150
   Iceland.....III-24
Spain.....III-24
The United Kingdom.....III-24
Overview.....III-24
1$75
   Role of Marine Algal Biomass in Energy Sector in UK.....III-25
Product Innovations/Introductions.....III-25
1$75
   Strategic Corporate Developments.....III-262$150
   Key Players.....III-284$300
   B. Market Analytics.....III-32
Table 22: European Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-32
1$200
   Table 23: European Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-331$200
   A. Market Analysis.....III-34
Outlook.....III-34
Australia.....III-34
China.....III-34
1$75
   India.....III-35
Marine Environment Offers Abundant Opportunities for R&D Initiatives.....III-35
Biotechnology Market in India on a Growth Trajectory.....III-35
1$75
   Seaweed: A Lucrative Marine Product.....III-36
Government Initiatives.....III-36
1$75
   New Zealand.....III-37
South Korea.....III-37
Strategic Corporate Developments.....III-37
1$75
   Marinova Pty Ltd (Australia) – A Key Player.....III-381$75
   B. Market Analytics.....III-39
Table 24: Asia-Pacific Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-39
1$200
   Table 25: Asia-Pacific Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-401$200
   A. Market Analysis.....III-41
Outlook.....III-41
Latin America.....III-41
Brazil.....III-41
1$75
   B. Market Analytics.....III-42
Table 26: Rest of World Recent Past, Current & Future Analysis for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-42
1$200
   Table 27: Rest of World Historic Review for Marine Biotechnology Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart).....III-431$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com